Innoviva Newsroom

Innoviva Analyst Ratings

BenzingaAug 1 13:10 ET

Innoviva Analyst Ratings

BenzingaJul 30 10:12 ET

Innoviva Analyst Ratings

BenzingaJun 18 08:12 ET

Analysts Offer Insights on Healthcare Companies: Lonza Group Ltd (Six Swiss: CH:LONN), Harrow Health (HROW) and Innoviva (INVA)

TipRanksApr 3 05:05 ET

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Innoviva (INVA) and Arcutis Biotherapeutics (ARQT)

TipRanksMay 10, 2023 08:40 ET

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

BenzingaMay 10, 2023 07:57 ET

Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Innoviva (INVA) and Pliant Therapeutics (PLRX)

TipRanksApr 20, 2023 12:43 ET

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

BenzingaApr 20, 2023 08:48 ET

What 4 Analyst Ratings Have To Say About Innoviva

BenzingaMar 3, 2023 16:03 ET

Morgan Stanley Sticks to Their Sell Rating for Innoviva (INVA)

TipRanksMar 3, 2023 11:31 ET

Goldman Sachs Remains a Hold on Innoviva (INVA)

TipRanksMar 3, 2023 11:31 ET

Morgan Stanley Adjusts Price Target on Innoviva to $10 From $13, Maintains Underweight Rating

MT NewswiresMar 3, 2023 10:43 ET

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

BenzingaMar 3, 2023 09:18 ET

Morgan Stanley Sticks to Its Sell Rating for Innoviva (INVA)

TipRanksJan 24, 2023 11:40 ET

Innoviva Analyst Ratings

Benzinga Analyst RatingsJan 24, 2023 08:57 ET

Morgan Stanley Maintains Underweight on Innoviva, Lowers Price Target to $13

Benzinga Real-time NewsJan 24, 2023 08:57 ET

Analysts Offer Insights on Healthcare Companies: Innoviva (INVA) and Envista Holdings (NVST)

TipRanksOct 13, 2022 12:50 ET

Morgan Stanley Adjusts Price Target on Innoviva to $14 From $13, Maintains Underweight Rating

MT NewswiresOct 13, 2022 10:21 ET

Innoviva Analyst Ratings

Benzinga Analyst RatingsOct 13, 2022 08:39 ET

Morgan Stanley Maintains Underweight on Innoviva, Raises Price Target to $14

Benzinga Real-time NewsOct 13, 2022 08:38 ET